Difference between revisions of "Part:BBa K5150000"
Line 3: | Line 3: | ||
<partinfo>BBa_K5150000</partinfo> | <partinfo>BBa_K5150000</partinfo> | ||
− | This multipeptide protein was carefully designed to integrate peptides with antidiabetic, antihypertensive, hypocholesterolemic and antithrombotic properties from food sources such as quinoa, soybean, goat milk, cow milk and calpis. It is optimized to be highly expressed in E. coli | + | ==Multipeptide sequence 3== |
+ | |||
+ | This multipeptide protein was carefully designed to integrate peptides with antidiabetic, antihypertensive, hypocholesterolemic and antithrombotic properties from food sources such as quinoa, soybean, goat milk, cow milk and calpis. It is optimized to be highly expressed in ''E. coli'' enabling straightforward purification through affinity chromatography. | ||
The main objective is to encapsulate the protein for oral ingestion so it could be released in the gut. Once released, the bioactive peptides are absorbed into the bloodstream, where they can modulate key metabolic pathways linked to diabetes and its complications. The protein can be used in projects related to nutrition studies, therapeutic natural products, food development or investigation of digestive proteases. | The main objective is to encapsulate the protein for oral ingestion so it could be released in the gut. Once released, the bioactive peptides are absorbed into the bloodstream, where they can modulate key metabolic pathways linked to diabetes and its complications. The protein can be used in projects related to nutrition studies, therapeutic natural products, food development or investigation of digestive proteases. | ||
Line 20: | Line 22: | ||
<partinfo>BBa_K5150000 parameters</partinfo> | <partinfo>BBa_K5150000 parameters</partinfo> | ||
<!-- --> | <!-- --> | ||
+ | |||
+ | |||
+ | <html> | ||
+ | <center> | ||
+ | <figure> | ||
+ | <img src='https://static.igem.wiki/teams/5150/parts/mp3.jpg' width='500px' height='200px' /> | ||
+ | <figcaption> | ||
+ | <b><small>Figure 1. Multipeptide sequence 1 for <i>E.coli</i>.</small></b> | ||
+ | </figcaption> | ||
+ | </figure> | ||
+ | </center> | ||
+ | </html> |
Revision as of 18:56, 30 September 2024
Multipeptide sequence 3
This multipeptide protein was carefully designed to integrate peptides with antidiabetic, antihypertensive, hypocholesterolemic and antithrombotic properties from food sources such as quinoa, soybean, goat milk, cow milk and calpis. It is optimized to be highly expressed in E. coli enabling straightforward purification through affinity chromatography.
The main objective is to encapsulate the protein for oral ingestion so it could be released in the gut. Once released, the bioactive peptides are absorbed into the bloodstream, where they can modulate key metabolic pathways linked to diabetes and its complications. The protein can be used in projects related to nutrition studies, therapeutic natural products, food development or investigation of digestive proteases.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]